Opioid Addiction

We listen to a recent episode of the Rumble Strip podcast about drug-related crime in Burlington and debate the best ways to tackle the opioid epidemic.

Kenneth Cadow's debut novel, Gather, is a finalist in the Young People’s Literature division for the 2023 National Book Award. The book follows Ian, a teenager in rural Vermont, as he deals with common teenager struggles, and something much bigger — his mom’s substance misuse disorder.

Vermont Edition convened a discussion about how our criminal justice system deals with people who have been accused of drug-related crimes like selling fentanyl.

A test strip that can detect the presence of a dangerous animal tranquilizer in street drugs may soon be more widely available in Vermont.

How the Johnson Health Center, which is part of a community-wide network centered around substance use recovery, is now tasked with rebuilding after the flooding.

KFF Health News obtained documents showing the exact dollar amounts — down to the cent — that local governments have been paid in 2022 and 2023 in lawsuit settlements from the opioid crisis.

Host Mikaela Lefrak speaks with the health commissioner on plans to bolster the state's response to opioid overdoses, as well as the importance of harm reduction with health experts.

A growing number of fatal opioid overdoses in Vermont involve an animal tranquilizer that blunts the effectiveness of overdose-reversing medications. It’s a trend that’s concerning health officials as the state experiences a high number of overdose deaths.

The cash represents an unprecedented opportunity to derail the opioid epidemic. But with countless groups advocating for a share of the pie, the impact could depend heavily on geography and politics.

After years of litigation and investigation against opioid manufacturers, money is coming in. Vermont is slated to receive more than $100 million the cases that have been settled so far, according to the attorney general’s office. That number will go up, because Vermont is slated to receive funds from recent national settlements with four drug makers that combined, total more than $8.5 billion.